Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study. [electronic resource] by
- Reich, K
- Rich, P
- Maari, C
- Bissonnette, R
- Leonardi, C
- Menter, A
- Igarashi, A
- Klekotka, P
- Patel, D
- Li, J
- Tuttle, J
- Morgan-Cox, M
- Edson-Heredia, E
- Friedrich, S
- Papp, K
Producer: 20200828
In:
The British journal of dermatology vol. 181
Availability: No items available.
|
|
10.
|
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. [electronic resource] by
- Papp, K A
- Reich, K
- Paul, C
- Blauvelt, A
- Baran, W
- Bolduc, C
- Toth, D
- Langley, R G
- Cather, J
- Gottlieb, A B
- Thaçi, D
- Krueger, J G
- Russell, C B
- Milmont, C E
- Li, J
- Klekotka, P A
- Kricorian, G
- Nirula, A
Producer: 20170724
In:
The British journal of dermatology vol. 175
Availability: No items available.
|